Non-vitamin K antagonist oral anticoagulants for the prevention of recurrent venous thromboembolism

Thrombosis Research ◽

10.1016/j.thromres.2016.05.022 ◽

2016 ◽

Vol 144 ◽

pp. 12-20 ◽

Author(s):

Rupert Bauersachs

Keyword(s):

Venous Thromboembolism ◽

Vitamin K ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Recurrent Venous Thromboembolism

Download Full-text

Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: A systemic review and meta-analysis

Thrombosis Research ◽

10.1016/j.thromres.2018.04.008 ◽

2018 ◽

Vol 166 ◽

pp. 37-42 ◽

Author(s):

Yugo Yamashita ◽

Takeshi Morimoto ◽

Toshiaki Toyota ◽

Hiroki Shiomi ◽

Takeru Makiyama ◽

...

Keyword(s):

Venous Thromboembolism ◽

Vitamin K ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Direct Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Systemic Review ◽

Efficacy And Safety ◽

Download Full-text

Effectiveness and Safety of Non–vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses

Clinical Therapeutics ◽

10.1016/j.clinthera.2017.05.358 ◽

2017 ◽

Vol 39 (7) ◽

pp. 1456-1478.e36 ◽

Author(s):

Abdulaali R. Almutairi ◽

Lili Zhou ◽

Walid F. Gellad ◽

Jeannie K. Lee ◽

Marion K. Slack ◽

...

Keyword(s):

Atrial Fibrillation ◽

Systematic Review ◽

Venous Thromboembolism ◽

Vitamin K ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Download Full-text

PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort

Thrombosis Research ◽

10.1016/s0049-3848(16)30173-6 ◽

2016 ◽

Vol 140 ◽

pp. S191 ◽

Author(s):

A. Mancuso ◽

M.C. Vedovati ◽

L. Pierpaoli ◽

U. Paliani ◽

S. Conti ◽

...

Keyword(s):

Venous Thromboembolism ◽

Vitamin K ◽

Prospective Cohort ◽

Oral Anticoagulants ◽

Real Life ◽

Vitamin K Antagonist ◽

Patients With Cancer

Download Full-text

Cryptogenic stroke prevention through venous thromboembolism prevention: Potential and truth in the advent of non-vitamin K antagonist oral anticoagulants

Journal of Cardiology Cases ◽

10.1016/j.jccase.2016.06.009 ◽

2016 ◽

Vol 14 (3) ◽

pp. 69-70

Author(s):

Kengo Ayabe ◽

Shinya Goto

Keyword(s):

Venous Thromboembolism ◽

Vitamin K ◽

Stroke Prevention ◽

Oral Anticoagulants ◽

Cryptogenic Stroke ◽

Vitamin K Antagonist ◽

Venous Thromboembolism Prevention ◽

Prevention Potential

Download Full-text

Extended treatment with non-vitamin K antagonist oral anticoagulants versus low-molecular-weight heparins in cancer patients following venous thromboembolism. A pilot study

Vascular Pharmacology ◽

10.1016/j.vph.2019.106567 ◽

2019 ◽

Vol 120 ◽

pp. 106567 ◽

Author(s):

Konrad Stepien ◽

Karol Nowak ◽

Jaroslaw Zalewski ◽

Agnieszka Pac ◽

Anetta Undas

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Pilot Study ◽

Cancer Patients ◽

Vitamin K ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Low Molecular Weight ◽

Low Molecular Weight Heparins ◽

Extended Treatment

Download Full-text

Decreased Bleeding Incidence with Direct Oral Anticoagulants Compared to Vitamin K Antagonist and Low Molecular Weight Heparin in Patients with Sickle Cell Disease and Venous Thromboembolism

Annals of Hematology & Oncology ◽

10.26420/annhematoloncol.2018.1208 ◽

2018 ◽

Vol 5 (5) ◽

Author(s):

Patel A

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Sickle Cell Disease ◽

Vitamin K ◽

Low Molecular Weight Heparin ◽

Oral Anticoagulants ◽

Direct Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Low Molecular Weight ◽

Download Full-text

Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism

Heart ◽

10.1136/heartjnl-2014-307019 ◽

2016 ◽

Vol 102 (12) ◽

pp. 975-983 ◽

Author(s):

Andrew D Blann ◽

Gregory Y H Lip

Keyword(s):

Venous Thromboembolism ◽

Vitamin K ◽

Oral Anticoagulants ◽

Vitamin K Antagonist

Download Full-text

Dalteparin vs. vitamin K antagonist (VKA) for the prevention of recurrent venous thromboembolism (VTE) in cancer patients with renal insufficiency: A patient level pharmacoeconomic analysis in three European countries

Annals of Oncology ◽

10.1093/annonc/mdw377.20 ◽

2016 ◽

Vol 27 ◽

pp. vi356

Author(s):

L. Shane ◽

G. Dranitsaris ◽

S. Woodruff ◽

J.-P. Galanaud ◽

G. Stemer ◽

...

Keyword(s):

Venous Thromboembolism ◽

Renal Insufficiency ◽

Cancer Patients ◽

Vitamin K ◽

Pharmacoeconomic Analysis ◽

Vitamin K Antagonist ◽

European Countries ◽

Patient Level ◽

Recurrent Venous Thromboembolism

Download Full-text

Effective management of venous thromboembolism in the community: non-vitamin K antagonist oral anticoagulants

International Journal of General Medicine ◽

10.2147/ijgm.s100299 ◽

2016 ◽

pp. 107 ◽

Author(s):

Raj Patel

Keyword(s):

Venous Thromboembolism ◽

Vitamin K ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Effective Management

Download Full-text

Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis

Heart ◽

10.1136/heartjnl-2015-307489 ◽

2015 ◽

Vol 101 (15) ◽

pp. 1204-1211 ◽

Author(s):

Daniel Caldeira ◽

Filipe B Rodrigues ◽

Márcio Barra ◽

Ana Teresa Santos ◽

Daisy de Abreu ◽

...

Keyword(s):

Atrial Fibrillation ◽

Systematic Review ◽

Venous Thromboembolism ◽

Vitamin K ◽

Major Bleeding ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Vitamin K Antagonist

Download Full-text